close
close
Benua

Bausch + Lomb’s enVista Envy IOL receives approval in Canada

Vaseline

Bausch + Lomb is also pursuing regulatory approval in other markets for the enVista Envy IOL. Credit: megaflopp/Shutterstock.com.

Eye health company Bausch + Lomb has received Health Canada approval for its enVista Envy full visual range (IOL) intraocular lens.

Built on the enVista IOL platform, the new lens is designed to provide patients with a full field of view and high tolerance for dysphotopsia, a common problem with glare and halos after surgery.

A multicenter, randomized, and controlled clinical trial in Canada has shown promising long-term results with the enVista Envy IOL.

Notably, 93% of patients experienced minimal dysphotopsia, and 94% had little to no difficulty with near vision, while maintaining excellent distance vision without glasses, with a continuous visual range of four diopters.

The enVista Envy IOL includes ActivSync Optic Intelligent Energy Distribution and ClearPath technology, which improves vision in a variety of lighting conditions and reduces light scatter.

Additionally, the enVista Envy IOL’s Low-Cyl toric technology addresses both presbyopia and low levels of astigmatism, providing more precise correction in increments of 0.5D or less throughout the cylinder range.

Gain access to the most comprehensive company profiles on the market, powered by GlobalData. Save hours of research. Gain competitive advantage.

Company Profile – Free Sample

Your download email will arrive shortly

We have confidence in the unique quality of our company profiles. However, we want you to make the most beneficial decision for your business. That’s why we offer you a free sample that you can download by submitting the form below.

By GlobalData







Please visit our Privacy Policy to learn more about our services, how we may use, process and share your personal data, including information about your rights in relation to your personal data and how to unsubscribe from future marketing communications. Our services are intended for business subscribers and you warrant that the email address provided is your business email address.

Luc Bonnefoy, global surgical president of Bausch + Lomb, said: “enVista Envy is the next step in the dramatic transformation of our IOL portfolio.

“This first premium IOL on the enVista platform follows the US launch of enVista Aspire late last year. The company plans to launch complementary designs in the coming months to complete the renowned enVista portfolio to better meet all patient needs.”

The enVista Envy IOLs are scheduled to be commercially available in Canada next month.

Bausch + Lomb is also pursuing regulatory approval in other markets, including the US and Europe, for the enVista Envy IOL.

Last year, Bausch and Lomb and Heidelberg Engineering launched the new SeeLumafully digital surgical visualization platform.


Related Posts